Home LiteratureArticle Details
PMID: 16259557 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Silencing and variegation of gammaretrovirus and lentivirus vectors.

Human gene therapy ·Vol. 16 ·No. 11 ·2005-11-00 ·Pages 1241-6

Ellis J

Abstract

Retrovirus vectors integrate into the genome, providing stable gene transfer, but integration contributes in part to transcriptional silencing that compromises long-term expression. In the case of gammaretrovirus vectors based on murine leukemia virus, many integration events are completely silenced in undifferentiated stem cells and in transgenic mice. Gammaretrovirus vectors are also subject to variegation in which sister cells bearing the same provirus differentially express, and cell differentiation can lead to extinction of vector expression. In contrast, lentivirus vectors based on human immunodeficiency virus type 1 appear to express more efficiently, although other reports indicate that lentivirus vectors can be silenced. This review summarizes the key features of gammaretrovirus vector silencing. The evidence for and against gene silencing of lentivirus vectors is described with special emphasis on the potential effects of vector design, provirus copy number, and integration site preferences on silencing. This analysis suggests that the difference between selfinactivating (SIN) lentivirus vectors and their modified SIN gammaretrovirus counterparts may be less dramatic than previously thought. It will therefore be important to further characterize the mechanisms of silencing, in order to create better gammaretrovirus and lentivirus vectors that consistently express at single copy for gene therapy.

MeSH Terms
Animals Gammaretrovirus/genetics Gene Silencing Genetic Vectors Lentivirus/genetics Mice Mice, Transgenic Stem Cells/virology Transcription, Genetic Virus Integration
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Ellis James
Developmental Biology Program, Hospital for Sick Children, Toronto, ON, Canada M5G 1L7. jellis@sickkids.ca
Article Info
Journal
Human gene therapy
Abbr.
Hum Gene Ther
ISSN
1043-0342
Published
2005-11-00
Pages
1241-6
Language
English
Region
United States
NLM ID
9008950
Subset
IM
Grants
NHLBI NIH HHS · 5-U54-HL070588 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com